Pharmaceutical giant Glaxo-SmithKline has confirmed plans to set up a full-scale antibiotics plant in Algeria, reported the Gulf News.
The company's board has approved the project, which is to be completed within 24 months, a senior official said.
"We are continuing to make significant investments where required, and the project in Algeria attests to that commitment," said Damien Carpanini, the UK-based vice-president for human resources responsible for the Middle East and North Africa (Mena).
Glaxo-SmithKline has also manufacturing plants in Saudi Arabia, Egypt, Morocco and Turkey, the paper said.
According to the paper, the Mena territory is expected to contribute about £420 million to the company's £16 billion in revenues predicted this year - Albawaba.com
© 2001 Al Bawaba (www.albawaba.com)
